Education
About Us
Working with TipRanks
Follow Us
Disc Medicine (IRON)
NASDAQ:IRON
Total Valuation
Disc Medicine has a market cap or net worth of $1.45B. The enterprise value is $1.43B.
Market Cap$1.45B
Enterprise Value$1.43B
Share Statistics
Disc Medicine has 34,569,042 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding34,569,042
Owned by Insiders26.59%
Owned by Institutions<0.01%
Financial Efficiency
Disc Medicine’s return on equity (ROE) is -0.22 and return on invested capital (ROIC) is -26.28%.
Return on Equity (ROE)-0.22
Return on Assets (ROA)-0.21
Return on Invested Capital (ROIC)-26.28%
Return on Capital Employed (ROCE)-0.26
Revenue Per Employee0.00
Profits Per Employee-909.87K
Employee Count84
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Disc Medicine is -16.86. Disc Medicine’s PEG ratio is 1.24.
PE Ratio-16.86
PS Ratio―
PB Ratio3.73
Price to Fair Value3.73
Price to FCF-17.52
Price to Operating Cash Flow-17.55
PEG Ratio1.24
Income Statement
In the last 12 months, Disc Medicine had revenue of 0.00 and earned -76.43M in profits. Earnings per share was -3.42.
Revenue0.00
Gross Profit-100.00K
Operating Income-91.13M
Pretax Income-76.33M
Net Income-76.43M
EBITDA-91.03M
Earnings Per Share (EPS)-3.42
Cash Flow
In the last 12 months, operating cash flow was -93.93M and capital expenditures -505.00K, giving a free cash flow of -94.43M billion.
Operating Cash Flow-93.93M
Free Cash Flow-94.43M
Free Cash Flow per Share-2.73
Dividends & Yields
Disc Medicine pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.74
52-Week Price Change63.00%
50-Day Moving Average50.01
200-Day Moving Average52.65
Relative Strength Index (RSI)47.39
Average Volume (3m)531.41K
Important Dates
Disc Medicine upcoming earnings date is May 19, 2025, TBA Not Confirmed.
Last Earnings DateFeb 27, 2025
Next Earnings DateMay 19, 2025
Ex-Dividend Date―
Financial Position
Disc Medicine as a current ratio of 17.06, with Debt / Equity ratio of 6.76%
Current Ratio17.06
Quick Ratio17.06
Debt to Market Cap0.00
Net Debt to EBITDA3.94
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Disc Medicine has paid 99.00K in taxes.
Income Tax99.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Disc Medicine EV to EBITDA ratio is -10.22, with an EV/FCF ratio of -12.65.
EV to Sales0.00
EV to EBITDA-10.22
EV to Free Cash Flow-12.65
EV to Operating Cash Flow-12.67
Balance Sheet
Disc Medicine has $489.88M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$459.88M billion.
Cash & Marketable Securities$489.88M
Total Debt$0.00
Net Cash-$459.88M
Net Cash Per Share-$13.30
Tangible Book Value Per Share$15.47
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Disc Medicine is $98.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$98.50
Price Target Upside134.19% Upside
Analyst ConsensusStrong Buy
Analyst Count11
Revenue Growth Forecast―
EPS Growth Forecast-14.19%